{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T11:30:34Z","timestamp":1771500634116,"version":"3.50.1"},"reference-count":9,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T00:00:00Z","timestamp":1708473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2024.1342915","type":"journal-article","created":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T11:04:26Z","timestamp":1708513466000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Commentary: Azathioprine as an adjuvant therapy in severe Graves\u2019 disease: a randomized controlled open-label clinical trial"],"prefix":"10.3389","volume":"15","author":[{"given":"Madhukar","family":"Mittal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Azher","family":"Rizvi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,2,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1168936","article-title":"Azathioprine as an adjuvant therapy in severe Graves\u2019 disease: a randomized controlled open-label clinical trial","volume":"14","author":"Allam","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2015.0647","article-title":"Does immunosuppressive therapy improve outcomes in Graves\u2019 Disease? A systematic review and meta-analysis","volume":"26","author":"Struja","year":"2016","journal-title":"Thyroid"},{"key":"B3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1159\/000508789","article-title":"Novel approaches for immunosuppression in Graves\u2019 Hyperthyroidism and associated orbitopathy","volume":"9","author":"Lee","year":"2020","journal-title":"Eur Thyroid J"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American thyroid association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1159\/000490384","article-title":"2018 European thyroid association guideline for the management of Graves\u2019 Hyperthyroidism","volume":"7","author":"Kahaly","year":"2018","journal-title":"Eur Thyroid J"},{"key":"B6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.12701\/jyms.2022.00444","article-title":"Long-term management of Graves disease: a narrative review","volume":"40","author":"Kim","year":"2022","journal-title":"J Yeungnam Med Sci"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-67-4-656","article-title":"Lasting remissions in patients treated for Graves\u2019 hyperthyroidism with propranolol alone: a pattern of spontaneous evolution of the disease","volume":"67","author":"Codaccioni","year":"1988","journal-title":"J Clin Endocrinol Metab"},{"key":"B8","article-title":"Assessment of early immunosuppressive therapy in the prevention of complications of Graves\u2019 disease","volume":"61","author":"Huszno","year":"2004","journal-title":"Przegl Lek"},{"key":"B9","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/S2213-8587(18)30021-4","article-title":"Combined immunosuppression and radiotherapy in thyroid eye disease (CIRTED): a multicentre, 2\u2008\u00d7\u20082 factorial, double-blind, randomised controlled trial","volume":"6","author":"Rajendram","year":"2018","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1342915\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T11:04:29Z","timestamp":1708513469000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2024.1342915\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,21]]},"references-count":9,"alternative-id":["10.3389\/fendo.2024.1342915"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2024.1342915","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,21]]},"article-number":"1342915"}}